{"id":1081967,"date":"2026-09-24T09:44:45","date_gmt":"2026-09-24T09:44:45","guid":{"rendered":"https:\/\/www.europesays.com\/us\/1081967\/"},"modified":"2026-09-24T09:44:45","modified_gmt":"2026-09-24T09:44:45","slug":"fda-issues-recall-for-common-blood-pressure-pill-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/1081967\/","title":{"rendered":"FDA Issues Recall for Common Blood Pressure Pill"},"content":{"rendered":"<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99806\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99806\">Food and Drug Administration<\/a> announced the recall of more than 13,500 bottles of a popular blood pressure medication. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\"><a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99806\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=99806\">The agency<\/a> said it recalled chlorthalidone tablets made by Inventia Healthcare Limited because they failed dissolution specifications. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The recall was initially issued on Sept. 3, but the FDA classified it as a Class II recall on Sept. 17. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The medication, which came in a 25mg dose, was distributed nationwide. They came in a 100-count bottle with NDC number 64980-599-01. It has batch number RISA24002 and an expiration date of 04\/2027.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">A Class II recall is \u201ca situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,\u201d according to the <a href=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\">FDA<\/a>.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">This is not the first time chlorthalidone has been recalled for this issue. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">In June, the same type of medication distributed by Rising Pharma Holdings was also recalled. It was also recalled for failed dissolution specifications, the <a href=\"https:\/\/www.wsoctv.com\/news\/trending\/recall-alert-11k-bottles-blood-pressure-medications-recalled\/YZPJOK4R45HPBKUVVSJZZB2F6E\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.wsoctv.com\/news\/trending\/recall-alert-11k-bottles-blood-pressure-medications-recalled\/YZPJOK4R45HPBKUVVSJZZB2F6E\/\">FDA said at the time<\/a>.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">Chlorthalidone, according to the <a href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/chlorthalidone-oral-route\/description\/drg-20071817\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/chlorthalidone-oral-route\/description\/drg-20071817\">Mayo Clinic<\/a>, is not only used to treat high blood pressure, but also fluid retention caused by congestive heart failure, severe liver disease or kidney disease. It is a diuretic or water pill, the <a href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/chlorthalidone-oral-route\/description\/drg-20071817\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/chlorthalidone-oral-route\/description\/drg-20071817\">institution<\/a> said.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph body-copyright\">\u00a92026 Cox Media Group<\/p>\n","protected":false},"excerpt":{"rendered":"The Food and Drug Administration announced the recall of more than 13,500 bottles of a popular blood pressure&hellip;\n","protected":false},"author":3,"featured_media":1080757,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[22531,42044,180328,201071,64,178695,180330,638,29664,8468,18849,453,201072,2327,26402,210,29671,12644,4630,68316,3221,1060,201073,67653,71420,13996,19153,200547,8148,27521,22587,22749,201074,31700,201075,201076,16776,8152,149173,1409,4063,67,132,201077,68],"class_list":["post-1081967","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-alert","tag-announcement","tag-blackboard","tag-bullhorn","tag-business","tag-businessman","tag-chalkboard","tag-company","tag-concept","tag-customer","tag-danger","tag-economics","tag-endanger","tag-hand","tag-hazard","tag-health","tag-holding","tag-information","tag-legal","tag-liability","tag-marketing","tag-medication","tag-megaphone","tag-message","tag-negligence","tag-problem","tag-product","tag-product-recall","tag-protection","tag-quality","tag-quality-control","tag-recall","tag-recalling","tag-regulations","tag-responsible","tag-revoking","tag-risk","tag-safety","tag-seller","tag-sign","tag-text","tag-united-states","tag-unitedstates","tag-unsafe","tag-us"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1081967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=1081967"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1081967\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/1080757"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=1081967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=1081967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=1081967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}